At Vigilare Biopharma, our Regulatory Intelligence (RI) solutions enable pharmaceutical and medical technology companies to design efficient strategies for product development, registration, and market entry across diverse jurisdictions. We analyze evolving global regulations to equip sponsors and marketing authorization holders with timely, accurate, and region-specific insights needed for compliance and commercialization success.
Our tailored RI offerings support the entire product lifecycle from pre-market feasibility and strategic planning to post-market monitoring ensuring informed regulatory decisions that minimize risks and accelerate approvals.
Vigilare Biopharma’s Drug Regulatory Intelligence (DRI) services are designed to help pharmaceutical and biopharmaceutical organizations navigate complex, country-specific regulatory environments. We understand that precise and up-to-date information can determine the success of product registration and launch.
Our Drug RI specialists deliver:
Our Medical Devices Regulatory Intelligence (MDRI) services provide critical insights to help manufacturers and distributors comply with varying national and regional device regulations. We support companies throughout the device registration, certification, and post-market phases, ensuring robust compliance management aligned with local authority expectations.
Key offerings include: